Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity.

Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. Abstract Text:

Pier Luigi Meroni,

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by an adaptive immune response against self-PL-binding proteins ending in the production of specific autoantibodies. Antiphospholipid antibodies (aPL; and in particular anti-beta2 glycoprotein I antibodies) are formal diagnostic markers and pathogenic antibodies. Although APS may be considered as an autoantibody-mediated disease, there is now evidence that aPL are necessary but not sufficient to trigger some of the clinical manifestations of the syndrome. For example, additional factors, such as mediators of the innate immunity are now recognized to play a key role as second hits able to induce the thrombotic events in the presence of the autoantibodies. The APS scenario is also supplemented by the influence of genetically determined factors. Finally, environmental agents - in particular infectious ones - were reported to act as triggers for the production of autoantibodies cross-reacting with PL-binding proteins as well as inflammatory stimuli that potentiate the aPL thrombogenic effect. Altogether these findings do support the concept of a mosaic of factors that participate to the pathogenesis of the syndrome at different levels.

Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. Publishing Authors By Initials

PL Meroni,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of autoimmunity

VOLUME: 30

Page Numbers: 99-103

Journal Abbreviation: J. Autoimmun.

ISSN: 0896-8411

DAY: 15

MONTH: 01

YEAR: 2008

Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8812164

Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity.

AFFILIATION: Department of Internal Medicine, University of Milan, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Autoimmun

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity Related Publications

• Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
• Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases).
• AutoAbSC.Org -- Autoantibody Standardization Committee in 2006.
• Chronic urticaria: A disease at a crossroad between autoimmunity and coagulation.
• Comment on percutaneous treatment of liver hydatid cysts.
• Diet assessment and the screening for osteoporosis: a survey in a healthy menopause population.
• Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties.
• Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.
• MID1 mutations in patients with X-linked Opitz G/BBB syndrome.
• Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity.
• Pathogenic anti-nucleosome antibodies.
• Persistent parvovirus B19-induced anemia in an HIV-infected patient under HAART. Case report and review of literature.
• Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
• Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies.
• Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome.
• [Benzidamine in dentistry]
• [Mixed tumor or pleomorphic adenoma of the cheek]
• [Not Available.]
• [Overbite]